论文部分内容阅读
应用过继性免疫疗法治疗人类晚期恶性肿瘤的研究，现已取得了长足的进展。从应用淋巴因子激活的杀伤细胞（ＬＡＫ细胞）进行过继性免疫治疗，到目前已发展至应用自身肿瘤浸润淋巴细胞（ＴＩＬ）进行肿瘤的过继性免疫治疗。我们在人脑胶质瘤浸润淋巴细胞的分离、制备及体内...
The application of adoptive immunotherapy for the treatment of advanced human malignancies has made great strides. Adoptive adoptive immunotherapy has been developed from adoptive lymphokine-activated killer cells (LAK cells) to the adoptive immunotherapy of tumors using its own tumor-infiltrating lymphocytes (TILs). We in human glioma infiltrating lymphocytes separation, preparation and in vivo ...